Creo Medical, a UK-based medical device developer backed by medical device company Pentax Medical, has raised £20m ($25m) through a placing ahead of a planned listing on Aim on December 9 2016.
In a regulatory filing yesterday, Creo said it has conditionally raised £20m through a placing at a price of £0.76 a share, which would yield a market capitalisation of about £61.3m upon admission to Aim.
The listing will provide an exit for Finance Wales and UK government-backed Angel…
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
